Nutraceutical excipients market to reach $5.78 billion by 2030 at 6.0% cagr, driven by growing demand for health and wellness.
Read More
Nucleotides supplements market to reach $4.74 billion by 2030 at 11.2% cagr, driven by growing demand for dietary supplements.
Read More
Nucleic acid therapeutics market to reach $14.07 billion by 2030 at 15.1% cagr, driven by increasing number of genetic and chronic diseases.
Read More
Nuclear medicine radioisotopes market to reach $12.75 billion by 2030 at 7.4% cagr, driven by rising cases of cardiovascular diseases.
Read More
Norovirus treatment market to reach $3.22 billion by 2030 at 10.6% cagr, driven by increasing prevalence of infectious diseases.
Read More
Non-viral gene delivery technologies market to reach $9.26 billion by 2030 at 15.1% cagr, driven by increasing demand for personalized medicine.
Read More
Non-viral drug delivery systems market to reach $19.07 billion by 2030 at 14.1% cagr, driven by increasing demand for personalized medicines.
Read More
Non-therapeutic biomolecules market to reach $56.43 billion by 2030 at 10.7% cagr, driven by rapidly increasing number of research and laboratory testing.
Read More
Non-Steroidal Anti-inflammatory Drugs Market Outlook 2026–2035: Growth Drivers and Industry Forecast
Non-steroidal anti-inflammatory drugs market to reach $29.96 billion by 2030 at 6.5% cagr, driven by increasing prevalence of musculoskeletal disorders and chronic pain.
Read More
Non-opioid pain treatment market to reach $84.36 billion by 2030 at 8.7% cagr, driven by rising incidence of sports-related injuries.
Read More